PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
Company Closes $6.2M Public Offering and Expands Clinical Program to Include Ewing-Related SarcomasConference Call and Live Audio Webcast Scheduled for […]
BERKELEY HEIGHTS, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]